Role of pRB dephosphorylation in cell cycle regulation.

pRB, the tumor suppressor product of the retinoblastoma susceptibility gene, is regarded as one of the key regulators of the cell cycle. This protein exerts its growth suppressive effect through its ability to bind and interact with a variety of cellular proteins. In turn, pRB binding and interacting ability is governed by its phosphorylation state. In recent years, this negative growth regulatory protein has captured a great deal of attention from investigators around the world due to its ability to modulate the activity of transcription regulatory proteins, enzymes which modify chromatin, and other cellular proteins which contribute to its complex role in mammalian cells. Hypophosphorylated pRB binds and sequesters transcription factors, most notably those of the E2F/DP family, inhibiting the transcription of genes required to traverse the G1 to S phase boundary. This cell cycle inhibitory function is abrogated when pRB undergoes phosphorylation mediated by cyclin/cdk complexes following cell stimulation by mitogens. Removal of these phosphates appears to be carried out by a multimeric complex of protein phosphatase type 1 (PP1) and noncatalytic regulatory subunits at the completion of mitosis. This dephosphorylation returns pRB to its active, growth suppressive state. While the mechanism of pRB phosphorylation has and continues to be extensively studied, dephosphorylation of pRB has received disproportionately less attention. The goal of this review is to revisit the role of pRB dephosphorylation in regulating the cell cycle. Emphasis will be placed on understanding the function and regulation of pRB during the cell cycle as well as our ever-expanding notions of pRB-PP1 interaction and the mechanism of pRB dephosphorylation at mitotic exit.

[1]  A. Pichler,et al.  A binding site for transcription factor E2F is a target for trans activation of murine thymidine kinase by polyomavirus large T antigen and plays an important role in growth regulation of the gene , 1993, Journal of virology.

[2]  L. Chin,et al.  Role of the INK4a Locus in Tumor Suppression and Cell Mortality , 1996, Cell.

[3]  J. Nevins,et al.  Regulation of the cyclin E gene by transcription factor E2F1. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. LaBaer,et al.  New functional activities for the p21 family of CDK inhibitors. , 1997, Genes & development.

[5]  R. Roeder,et al.  Isolation and partial characterization of the multiple forms of deoxyribonucleic acid-dependent ribonucleic acid polymerase in the mouse myeloma, MOPC 315. , 1974, The Journal of biological chemistry.

[6]  Chun-Ming Huang,et al.  SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family , 1989, Cell.

[7]  E. Rubin,et al.  Protein Phosphatase Type 1, The Product of the Retinoblastoma Susceptibility Gene, And Cell Cycle Control , 1998 .

[8]  Lingyun Zhu,et al.  Differential roles of two tandem E2F sites in repression of the human p107 promoter by retinoblastoma and p107 proteins , 1995, Molecular and cellular biology.

[9]  M. Serrano,et al.  A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma , 1995, Science.

[10]  A. Simeone,et al.  Activation of major histocompatibility complex class I mRNA containing an Alu-like repeat in polyoma virus-transformed rat cells , 1985, Nature.

[11]  R. Weinberg,et al.  Growth suppression by p16ink4 requires functional retinoblastoma protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Pajovic,et al.  Identification of a viral kinase that phosphorylates specific E2Fs and pocket proteins , 1997, Molecular and cellular biology.

[13]  Tony Kouzarides,et al.  Retinoblastoma protein recruits histone deacetylase to repress transcription , 1998, Nature.

[14]  D. Nelson,et al.  Characterization of the mitotic phase pRb-directed protein phosphatase activity , 1997, Oncogene.

[15]  M. Botchan,et al.  Expression of enhanced levels of small RNA polymerase III transcripts encoded by the B2 repeats in simian virus 40-transformed mouse cells , 1985, Nature.

[16]  P. Cohen,et al.  The glycogen-binding subunit of protein phosphatase-1G from rabbit skeletal muscle. Further characterisation of its structure and glycogen-binding properties. , 1989, European journal of biochemistry.

[17]  M. Mumby,et al.  Distinct Roles for PP1 and PP2A in Phosphorylation of the Retinoblastoma Protein , 1999, The Journal of Biological Chemistry.

[18]  David M. Livingston,et al.  The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element , 1989, Cell.

[19]  J. Harper,et al.  Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. , 1997, Molecular biology of the cell.

[20]  J. Bartek,et al.  Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint , 1996, Molecular and cellular biology.

[21]  Identification of members of the protein phosphatase 1 gene family in the rat and enhanced expression of protein phosphatase 1 alpha gene in rat hepatocellular carcinomas. , 1991, Japanese journal of cancer research : Gann.

[22]  Jean Y. J. Wang,et al.  Differential Regulation of Retinoblastoma Protein Function by Specific Cdk Phosphorylation Sites (*) , 1996, The Journal of Biological Chemistry.

[23]  J. Nevins,et al.  Identification of a cellular transcription factor involved in E1A trans-activation , 1986, Cell.

[24]  R. Weinberg,et al.  Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[25]  A. Schönthal,et al.  Inhibitory phosphorylation of PP1alpha catalytic subunit during the G(1)/S transition. , 1999, The Journal of biological chemistry.

[26]  J. Massagué,et al.  Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. , 1995, Genes & development.

[27]  L. Taylor,et al.  Activity of RNA polymerase I transcription factor UBF blocked by Rb gene product , 1995, Nature.

[28]  J. Nevins,et al.  Distinct mechanisms control the accumulation of the Rb-related p107 and p130 proteins during cell growth. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[29]  T. Toda,et al.  The fission yeast dis2 + gene required for chromosome disjoining encodes one of two putative type 1 protein phosphatases , 1989, Cell.

[30]  Kristian Helin,et al.  Cell Cycle-Regulated Expression of MammalianCDC6 Is Dependent on E2F , 1998, Molecular and Cellular Biology.

[31]  S. Elledge,et al.  p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. , 1995, Genes & development.

[32]  C. Y. Wang,et al.  Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein. , 1993, Science.

[33]  A. Yen,et al.  Hypophosphorylation of the RB protein in S and G2 as well as G1 during growth arrest. , 1998, Experimental cell research.

[34]  A. Yen,et al.  Late dephosphorylation of the RB protein in G2 during the process of induced cell differentiation. , 1994, Experimental cell research.

[35]  P. Cohen,et al.  An improved procedure for identifying and quantitating protein phosphatases in mammalian tissues , 1989, FEBS letters.

[36]  T. Hunter,et al.  Okadaic acid, a potent inhibitor of type 1 and type 2A protein phosphatases, activates cdc2/H1 kinase and transiently induces a premature mitosis‐like state in BHK21 cells. , 1990, The EMBO journal.

[37]  N. Berndt,et al.  Constitutively active protein phosphatase 1α causes Rb-dependent G1 arrest in human cancer cells , 1997, Current Biology.

[38]  S. Elledge,et al.  Protein phosphatase 1 interacts with p53BP2, a protein which binds to the tumour suppressor p53 , 1995, FEBS letters.

[39]  E. Wintersberger,et al.  Histone Deacetylase 1 Can Repress Transcription by Binding to Sp1 , 1999, Molecular and Cellular Biology.

[40]  P. Dirks,et al.  Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation. , 1996, Critical reviews in biochemistry and molecular biology.

[41]  H. Nasheuer,et al.  Human DNA polymerase alpha gene: sequences controlling expression in cycling and serum-stimulated cells , 1991, Molecular and cellular biology.

[42]  N. Dyson,et al.  The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations. , 1990, The EMBO journal.

[43]  G. Hannon,et al.  p21-containing cyclin kinases exist in both active and inactive states. , 1994, Genes & development.

[44]  P. Greengard,et al.  Cell cycle-dependent phosphorylation of mammalian protein phosphatase 1 by cdc2 kinase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[45]  R. Weinberg,et al.  Physical interaction of the retinoblastoma protein with human D cyclins , 1993, Cell.

[46]  W. Lee,et al.  C-terminal truncation of the retinoblastoma gene product leads to functional inactivation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[47]  A. Gavin,et al.  Induction of M-phase entry of prophase-blocked mouse oocytes through microinjection of okadaic acid, a specific phosphatase inhibitor. , 1991, Experimental cell research.

[48]  M. Kitagawa,et al.  The consensus motif for phosphorylation by cyclin D1‐Cdk4 is different from that for phosphorylation by cyclin A/E‐Cdk2. , 1996, The EMBO journal.

[49]  Tony Hunter,et al.  p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21 , 1994, Cell.

[50]  W. Lee,et al.  Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. , 1990, Science.

[51]  R. Weinberg,et al.  Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[52]  P. J. Welch,et al.  A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle , 1993, Cell.

[53]  W. Lee,et al.  Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[54]  K. Münger,et al.  Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein , 1992, Journal of virology.

[55]  P. Rigby,et al.  Regulation of RNA polymerase III transcription in response to Simian virus 40 transformation. , 1990, The EMBO journal.

[56]  James M. Roberts,et al.  Cloning of p27 Kip1 , a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals , 1994, Cell.

[57]  M. Roussel,et al.  Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6 , 1995, Molecular and cellular biology.

[58]  A. Bielawska,et al.  Phosphatidic Acid Is a Potent And Selective Inhibitor of Protein Phosphatase 1 and an Inhibitor of Ceramide-mediated Responses* , 1999, The Journal of Biological Chemistry.

[59]  David M. Livingston,et al.  Functional interactions of the retinoblastoma protein with mammalian D-type cyclins , 1993, Cell.

[60]  Phang-lang Chen,et al.  Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation , 1989, Cell.

[61]  P. Cohen,et al.  The myosin-bound form of protein phosphatase 1 (PP-1M) is the enzyme that dephosphorylates native myosin in skeletal and cardiac muscles , 1988 .

[62]  N. Krucher,et al.  Hypoxia-induced pRB hypophosphorylation results from downregulation of CDK and upregulation of PP1 activities , 1998, Oncogene.

[63]  K. Münger,et al.  Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. , 1989, The EMBO journal.

[64]  M. Vidal,et al.  The retinoblastoma protein binds to a family of E2F transcription factors , 1993, Molecular and cellular biology.

[65]  J. Pouysségur,et al.  Cyclin D1 Expression Is Regulated Positively by the p42/p44MAPK and Negatively by the p38/HOGMAPK Pathway* , 1996, The Journal of Biological Chemistry.

[66]  T. L. McGee,et al.  Structure and partial genomic sequence of the human retinoblastoma susceptibility gene. , 1989, Gene.

[67]  V. Pant,et al.  The molecular and functional characterization of E2F-5 transcription factor. , 1998, Biochemical and biophysical research communications.

[68]  P. Rigby,et al.  Activation of mouse genes in transformed cells , 1983, Cell.

[69]  X. Graña,et al.  The p130 pocket protein: keeping order at cell cycle exit/re-entrance transitions. , 1998, Frontiers in bioscience : a journal and virtual library.

[70]  P. Whyte,et al.  Identification of a p130 domain mediating interactions with cyclin A/cdk 2 and cyclin E/cdk 2 complexes , 1997, Oncogene.

[71]  P. Cohen,et al.  The protein phosphatases involved in cellular regulation , 1984 .

[72]  R. Weinberg,et al.  Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. , 1996, Oncogene.

[73]  L. Obeid,et al.  Cell-cycle-dependent changes in ceramide levels preceding retinoblastoma protein dephosphorylation in G2/M. , 1998, The Biochemical journal.

[74]  B. Henglein,et al.  Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E 2 F site , 2022 .

[75]  X. Graña,et al.  G1 cyclin/CDK-independent phosphorylation and accumulation of p130 during the transition from G1 to G0 lead to its association with E2F-4. , 1996, Oncogene.

[76]  J. Harbour,et al.  Cdk Phosphorylation Triggers Sequential Intramolecular Interactions that Progressively Block Rb Functions as Cells Move through G1 , 1999, Cell.

[77]  J. Bartek,et al.  Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity , 1995, Molecular and cellular biology.

[78]  V. Richon,et al.  Regulation and Expression of Retinoblastoma Proteins p107 and p130 during 3T3-L1 Adipocyte Differentiation* , 1997, The Journal of Biological Chemistry.

[79]  S. Jackson,et al.  Repression of RNA polymerase III transcription by the retinoblastoma protein , 1996, Nature.

[80]  P. Robbins,et al.  The human retinoblastoma susceptibility gene promoter is positively autoregulated by its own product. , 1994, The Journal of biological chemistry.

[81]  D. Kimelman,et al.  E1a regions of the human adenoviruses and of the highly oncogenic simian adenovirus 7 are closely related , 1985, Journal of virology.

[82]  S. Mittnacht,et al.  Binding of select forms of pRB to protein phosphatase type 1 independent of catalytic activity , 1999, Oncogene.

[83]  J. Bartek,et al.  Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16 , 1995, Nature.

[84]  J. Nevins,et al.  Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to cell growth signals , 1997, Molecular and cellular biology.

[85]  R. White,et al.  Regulation of RNA polymerases I and III by the retinoblastoma protein: a mechanism for growth control? , 1997, Trends in biochemical sciences.

[86]  L. Hengst,et al.  Complete inhibition of Cdk/cyclin by one molecule of p21(Cip1). , 1998, Genes & development.

[87]  D. Beach,et al.  Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. , 1993, Genes & development.

[88]  M. Ewen,et al.  Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. , 1993, Genes & development.

[89]  S. Elledge,et al.  The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. , 1993, Genes & development.

[90]  D. Nelson,et al.  High Molecular Weight Protein Phosphatase Type 1 Dephosphorylates the Retinoblastoma Protein* , 1997, The Journal of Biological Chemistry.

[91]  P. Cohen,et al.  Purification of the hepatic glycogen‐associated form of protein phosphatase‐1 by microcystin‐Sepharose affinity chromatography , 1995, FEBS letters.

[92]  T. Sugimura,et al.  Protein phosphatase 1γ2 is associated with nuclei of meiotic cells in rat testis , 1993 .

[93]  M. Ewen,et al.  An N-Terminal transformation-governing sequence of SV40 large T antigen contributes to the binding of both p110 Rb and a second cellular protein, p120 , 1989, Cell.

[94]  A. Schönthal,et al.  Inhibitory Phosphorylation of PP1α Catalytic Subunit during the G1/S Transition* , 1999, The Journal of Biological Chemistry.

[95]  X. Graña,et al.  Cell cycle-dependent phosphorylation of the retinoblastoma-related protein p130. , 1995, Oncogene.

[96]  D. Nelson,et al.  Control and activity of type-1 serine/threonine protein phosphatase during the cell cycle. , 1995, Seminars in cancer biology.

[97]  T. L. McGee,et al.  Oncogenic germ-line mutations in Sp1 and ATF sites in the human retinoblastoma gene , 1991, Nature.

[98]  P. Greengard,et al.  Isolation and Characterization of PNUTS, a Putative Protein Phosphatase 1 Nuclear Targeting Subunit* , 1998, The Journal of Biological Chemistry.

[99]  D. Livingston,et al.  The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T , 1990, Cell.

[100]  A. Takai,et al.  Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. , 1988, The Biochemical journal.

[101]  Stephen H. Friend,et al.  Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product , 1988, Nature.

[102]  W. Sellers,et al.  Interaction between the retinoblastoma protein and the oncoprotein MDM2 , 1995, Nature.

[103]  D. Riley,et al.  The retinoblastoma protein: more than a tumor suppressor. , 1994, Annual review of cell biology.

[104]  H. C. Smith,et al.  Hypoxic stress induces reversible hypophosphorylation of pRB and reduction in cyclin A abundance independent of cell cycle progression. , 1993, Oncogene.

[105]  R. Bernards,et al.  Functional interaction between a novel protein phosphatase 2A regulatory subunit, PR59, and the retinoblastoma-related p107 protein , 1999, Oncogene.

[106]  Y. Hannun,et al.  Retinoblastoma protein dephosphorylation induced by D-erythro-sphingosine. , 1992, The Journal of biological chemistry.

[107]  Wen-Hwa Lee,et al.  SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene , 1988, Cell.

[108]  D. Livingston,et al.  Specific enzymatic dephosphorylation of the retinoblastoma protein , 1993, Molecular and cellular biology.

[109]  Y. Hannun,et al.  Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[110]  K. Yokoyama,et al.  The retinoblastoma gene product RB stimulates Sp1-mediated transcription by liberating Sp1 from a negative regulator , 1994, Molecular and cellular biology.

[111]  P. Cohen,et al.  Protein phosphatases: properties and role in cellular regulation. , 1983, Science.

[112]  R. Kerkhoven,et al.  Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. , 1995, Genes & development.

[113]  M. Kasten,et al.  The RB family of cell cycle regulatory factors. , 1998, Journal of cellular biochemistry. Supplement.

[114]  L. Leffet,et al.  Analysis of site-specific phosphorylation of the retinoblastoma protein during cell cycle progression. , 1999, Experimental Cell Research.

[115]  M. Bollen,et al.  The isolation of novel inhibitory polypeptides of protein phosphatase 1 from bovine thymus nuclei. , 1992, The Journal of biological chemistry.

[116]  M. Ewen,et al.  Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product , 1990, Molecular and cellular biology.

[117]  R. Beijersbergen,et al.  Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins. , 1996, Biochimica et biophysica acta.

[118]  A. Yen,et al.  Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. , 1989, Science.

[119]  W. Lee,et al.  Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen. , 1990, The EMBO journal.

[120]  M. Skolnick,et al.  A cell cycle regulator potentially involved in genesis of many tumor types. , 1994, Science.

[121]  D. Mann,et al.  Protein serine/threonine phosphatases; an expanding family , 1990, FEBS letters.

[122]  W. Lee,et al.  Structure of the human retinoblastoma gene. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[123]  X. Graña,et al.  Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth , 1998, Oncogene.

[124]  M. Skolnick,et al.  Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus , 1994, Nature Genetics.

[125]  R. Bernards,et al.  E2F: a nodal point in cell cycle regulation. , 1997, Biochimica et biophysica acta.

[126]  A. Schulze,et al.  Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[127]  D. Johnson,et al.  Role of E2F in cell cycle control and cancer. , 1998, Frontiers in bioscience : a journal and virtual library.

[128]  F. Kaye,et al.  A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[129]  J. Nevins,et al.  Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes , 1995, Molecular and cellular biology.

[130]  K. Münger,et al.  The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. , 1989, Science.

[131]  K. Moberg,et al.  E2F activity is regulated by cell cycle-dependent changes in subcellular localization , 1997, Molecular and cellular biology.

[132]  L. Zhu,et al.  E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. , 1994, Genes & development.

[133]  Marc Vidal,et al.  A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F , 1992, Cell.

[134]  F. Huang,et al.  Separation and characterization of two phosphorylase phosphatase inhibitors from rabbit skeletal muscle. , 1976, European journal of biochemistry.

[135]  P. Farnham,et al.  Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter. , 1994, Genes & development.

[136]  W. Sellers,et al.  Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter , 1994, Molecular and cellular biology.

[137]  E. Moran,et al.  A region of SV40 large T antigen can substitute for a transforming domain of the adenovirus E1A products , 1988, Nature.

[138]  A. Schönthal,et al.  Autoregulation of Protein Phosphatase Type 2A Expression* , 1998, The Journal of Biological Chemistry.

[139]  E. Harlow,et al.  The retinoblastoma protein is phosphorylated during specific phases of the cell cycle , 1989, Cell.

[140]  Y. Taya,et al.  Inactivation of oncoprotein binding by a single Cys706‐to‐Tyr substitution in the retinoblastoma protein , 1994, FEBS letters.

[141]  K. Helin,et al.  E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription , 1998, Oncogene.

[142]  Robert A. Weinberg,et al.  Functional Inactivation of the Retinoblastoma Protein Requires Sequential Modification by at Least Two Distinct Cyclin-cdk Complexes , 1998, Molecular and Cellular Biology.

[143]  J. Bartek,et al.  Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression , 1996, Molecular and cellular biology.

[144]  D. Rappolee,et al.  A single Cys706 to Phe substitution in the retinoblastoma protein causes the loss of binding to SV40 T antigen. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[145]  T. Sugimura,et al.  Identification of Members of the Protein Phosphatase 1 Gene Family in the Rat and Enhanced Expression of Protein Phosphatase 1α Gene in Rat Hepatocellular Carcinomas , 1990, Japanese journal of cancer research : Gann.

[146]  B. Gallie,et al.  Cumulative Effect of Phosphorylation of pRB on Regulation of E2F Activity , 1999, Molecular and Cellular Biology.

[147]  S. Dalton,et al.  Cell cycle regulation of the human cdc2 gene. , 1992, The EMBO journal.

[148]  R. Bernards,et al.  Rapid dephosphorylation of p107 following UV irradiation , 1999, Oncogene.

[149]  Hua,et al.  Identification of , 2000, Journal of insect physiology.

[150]  D. Glover,et al.  One of the protein phosphatase 1 isoenzymes in Drosophila is essential for mitosis , 1990, Cell.

[151]  D. Brautigan,et al.  Protein phosphatase type 1 in mammalian cell mitosis: chromosomal localization and involvement in mitotic exit , 1992, The Journal of cell biology.

[152]  David Beach,et al.  p21 is a universal inhibitor of cyclin kinases , 1993, Nature.

[153]  S. Elledge,et al.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.

[154]  L. Magnaghi-Jaulin,et al.  Retinoblastoma protein represses transcription by recruiting a histone deacetylase , 1998, Nature.

[155]  P. Farnham,et al.  A protein synthesis-dependent increase in E2F1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter , 1993, Molecular and cellular biology.

[156]  J. Blanchard,et al.  Cyclin A expression is under negative transcriptional control during the cell cycle , 1996, Molecular and cellular biology.

[157]  N. Krucher,et al.  Molecular analysis of selected cell cycle regulatory proteins during aerobic and hypoxic maintenance of human ovarian carcinoma cells , 1999, British Journal of Cancer.

[158]  Sibylle Mittnacht,et al.  Differential Phosphorylation of the Retinoblastoma Protein by G1/S Cyclin-dependent Kinases* , 1997, The Journal of Biological Chemistry.

[159]  J. Herman,et al.  5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers , 1995, Nature Medicine.

[160]  P. Cohen,et al.  A myofibrillar protein phosphatase from rabbit skeletal muscle contains the beta isoform of protein phosphatase-1 complexed to a regulatory subunit which greatly enhances the dephosphorylation of myosin. , 1992, European journal of biochemistry.

[161]  P. Cohen,et al.  Okadaic acid: a new probe for the study of cellular regulation. , 1990, Trends in biochemical sciences.

[162]  P. Cohen,et al.  Identification of a third form of protein phosphatase 1 in rabbit skeletal muscle that is associated with myosin. , 1988, Biochimica et biophysica acta.

[163]  J. Doonan,et al.  The bimG gene of Aspergillus nidulans, required for completion of anaphase, encodes a homolog of mammalian phosphoprotein phosphatase 1 , 1989, Cell.

[164]  P. Greengard,et al.  Cell cycle-dependent phosphorylation of mammalian protein phosphatase 1 by cdc 2 kinase , 1997 .

[165]  Joseph R. Nevins,et al.  The E2F transcription factor is a cellular target for the RB protein , 1991, Cell.

[166]  J. Nevins,et al.  Expression of transcription factor E2F1 induces quiescent cells to enter S phase , 1993, Nature.

[167]  J. Herman,et al.  Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia. , 1998, Cancer research.

[168]  W. Clark,et al.  Germline p16 mutations in familial melanoma , 1994, Nature Genetics.

[169]  P. Cohen,et al.  The protein phosphatases involved in cellular regulation. 6. Measurement of type-1 and type-2 protein phosphatases in extracts of mammalian tissues; an assessment of their physiological roles. , 1983, European journal of biochemistry.